Wolverine Trading’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2127 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2250 |
|
|
2021
Q3 | – | Sell |
-13,482
| Closed | -$40K | – | 2341 |
|
|
2021
Q2 | $40K | Sell |
13,482
-3,872
| -22% | -$11.5K | ﹤0.01% | 1714 |
|
|
2021
Q1 | $39K | Buy |
+17,354
| New | +$39K | ﹤0.01% | 1727 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1848 |
|
|
2019
Q3 | – | Sell |
-13,323
| Closed | -$15K | – | 1680 |
|
|
2019
Q2 | $15K | Sell |
13,323
-14,848
| -53% | -$16.7K | ﹤0.01% | 1176 |
|
|
2019
Q1 | $37K | Buy |
+28,171
| New | +$37K | ﹤0.01% | 1146 |
|
|
2018
Q4 | – | Sell |
-14,497
| Closed | -$30K | – | 1737 |
|
|
2018
Q3 | $30K | Buy |
14,497
+546
| +4% | +$1.13K | ﹤0.01% | 1439 |
|
|
2018
Q2 | $33K | Hold |
13,951
| – | – | ﹤0.01% | 1337 |
|
|
2018
Q1 | $33K | Sell |
13,951
-18,487
| -57% | -$43.7K | ﹤0.01% | 1337 |
|
|
2017
Q4 | $61K | Buy |
+32,438
| New | +$61K | ﹤0.01% | 1443 |
|
|
2017
Q3 | – | Sell |
-16,017
| Closed | -$44K | – | 1647 |
|
|
2017
Q2 | $44K | Sell |
16,017
-4,566
| -22% | -$12.5K | ﹤0.01% | 1186 |
|
|
2017
Q1 | $60K | Buy |
+20,583
| New | +$60K | ﹤0.01% | 1135 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1649 |
|
|
2016
Q3 | – | Sell |
-26,559
| Closed | -$58K | – | 1590 |
|
|
2016
Q2 | $58K | Buy |
+26,559
| New | +$58K | ﹤0.01% | 819 |
|